Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Angiotensin converting enzyme inhibitors (ACEi) are routinely used as first line treatment for hypertensive patients because of their protective effects against heart and kidney disease. Despite their clinical benefits, ACEi used is associated with adverse side effects such as life threatening angio...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of Medical Biochemistry
2015
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|